Based on the clinical diagnosis [using the tumor, nodes and metastasis grading system], 44.0% of phase I-II HCC tissues (n=11/25) demonstrated low levels of HSF1 protein expression, which was significantly different to the 83.3% of phase III and IV HCC tissues that exhibited high HSF1 expression. The gene discussed is HSF1; the disease is hepatocellular carcinoma.